The Biden administration and the maker of mifepristone asked the Court to reverse an appellate ruling that would cut off access to the drug through the mail and impose other restrictions ...
The initiative comes after a new state law reclassified the reproductive care drugs misoprostol and mifepristone as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback